On Friday, Abengoa Yield PLC (NASDAQ:ABY)’s shares inclined 4.55% to $22.53.
Abengoa Yield (ABY), the sustainable total return company that owns a diversified portfolio of contracted assets in the energy and environment sectors, stated revenues of $308.6 million for the six months ended June 30, 2015, representing an 82% enhance y-o-y and Further Adjusted EBITDA counting unmerged associates of $264.8 million, representing a 93% enhance contrast to the same period of 2014. Cash Accessible for Distribution for the six months reached $83.1 million, with a contribution in the second quarter of $44.6 million.
Solar assets have exceeded expectations due to better solar radiation levels than budget, especially in Europe. Wind assets in South America, representing a small portion of our portfolio, have practiced poorer than predictable wind resource. Mojave is delivering systematically above 90% of the performance model of a fully optimized plant, which is very successful for a large plant with only seven months of operations. Solana is also performing in line with its target, having reached record daily production above 4 GWh per day.
Abengoa Yield plc owns a portfolio of renewable energy, conventional power, and electric transmission line contracted assets in North America, South America, and Europe. The companys renewable energy assets comprise 2 solar power plants each with a gross capacity of 280 megawatts (MW) in the United States; 1 on-shore wind farm with a gross capacity of 50 MW in Uruguay; and 2 solar power plants each with a gross capacity of 50 MW in Spain. Its conventional power asset comprises a 300 MW cogeneration plant in Mexico.
American Tower Corp (NYSE:AMT)’s shares gained 1.31% to $99.65.
American Tower Corporation (AMT) declared that its Executive Vice President and President, U.S. Tower Division, Steven Marshall, is planned to speak at the Cowen Communications Infrastructure Summit in Boulder, Colorado on Wednesday, August 12, 2015 at 12:45 p.m. MT. The live audio webcast link will be accessible on the Company’s website, www.americantower.com.
American Tower Corporation is a real estate investment trust. It invests in the real estate markets across the globe. The firm engages in leasing of space on multi-tenant communications sites to wireless service providers, radio and television broadcast companies, wireless data and data providers, government agencies and municipalities and tenants in a number of other industries. American Tower Corporation was founded in 1995 and is headquartered in Boston, Massachusetts.
At the end of Friday’s trade, Geron Corporation (NASDAQ:GERN)‘s shares dipped -2.17% to $3.61.
Geron Corporation (GERN) stated financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Results
For the second quarter of 2015, the company stated a net loss of $9.4 million, or $0.06 per share, contrast to $8.7 million, or $0.06 per share, for the comparable 2014 period. Revenues for the second quarter of 2015 were $251,000 contrast to $341,000 for the comparable 2014 period. Interest and other income for the second quarter of 2015 amounted to $145,000 contrast to $99,000 for the comparable 2014 period. The company ended the second quarter of 2015 with $157.0 million in cash and investments.
Total operating expenses for the second quarter of 2015 were $9.7 million contrast to $9.0 million for the comparable 2014 period. Research and development expenses for the second quarter of 2015 were $4.8 million contrast to $5.2 million for the comparable 2014 period. General and administrative expenses for the second quarter of 2015 were $4.0 million contrast to $3.9 million for the comparable 2014 period. Operating expenses for the 2015 second quarter also comprised of restructuring charges of $941,000 in connection with the company’s organ
Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. It has partnership and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, counting hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
Integrated Device Technology Inc (NASDAQ:IDTI), ended its Friday’s trading session with 0.96% gain, and closed at $19.97.
Integrated Device Technology, Inc. (IDTI) declared that registration is open for the Double Racing Festival’s return to San Jose on Aug. 22. The centerpiece of the unique family-friendly festival is the Double Road Race 15K, which splits the race into two legs—a 10K and a 5K, with a break in between. The race was developed by Bob Anderson, founder of Runner’s World magazine.
The race starts and ends at the headquarters of IDT, the presenting sponsor of the San Jose event. Times from the two legs are combined for scoring.
The festival will feature live music and food. In addition to the Double Road Race, two additional racing events are planned at the festival. The UjENA Double 5K features a 3K leg and a 2K leg. Children 13 and younger can take part in the 1.5-mile Kids Cup Double, with a 1-mile leg followed by a half-mile leg. All races comprise a halftime. All Double Road Race finishers receive a medal, official race T-shirt, and a draw-string tote bag.
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer. The Communications segment offers communication timing products, such as clocks and timing solutions; flow-control administration devices comprising Serial RapidIO switching solutions; multi-port products; telecommunications products; static random access memory products; first in and first out memories; digital logic products; radio frequency products; and MEMS oscillator solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
